{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:03:19Z","timestamp":1789747399690,"version":"4.0.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.soc.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T05:51:29Z","timestamp":1605765089000},"page":"69-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Surgical Management of Gynecologic Cancers"],"prefix":"10.1016","volume":"30","author":[{"given":"Kiran H.","family":"Clair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Wolford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Zell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Bristow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.soc.2020.09.004_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib2","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib3","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ygyno.2018.06.022","article-title":"Sites of distant metastases and overall survival in ovarian cancer: a study of 1481 patients","volume":"150","author":"Deng","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10585-019-10007-0","article-title":"Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes","volume":"37","author":"Gardner","year":"2020","journal-title":"Clin Exp Metastasis"},{"issue":"7","key":"10.1016\/j.soc.2020.09.004_bib5","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/1097-0142(19891001)64:7<1508::AID-CNCR2820640725>3.0.CO;2-V","article-title":"Metastatic patterns in histologic variants of ovarian cancer. An autopsy study","volume":"64","author":"Rose","year":"1989","journal-title":"Cancer"},{"issue":"S2","key":"10.1016\/j.soc.2020.09.004_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ijgo.12614","article-title":"Cancer of the ovary, fallopian tube, and peritoneum","volume":"143","author":"Berek","year":"2018","journal-title":"Int J Gynecol Obstet"},{"issue":"9","key":"10.1016\/j.soc.2020.09.004_bib7","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.3390\/ijms130911705","article-title":"Mechanisms of ovarian cancer metastasis: biochemical pathways","volume":"13","author":"Nakayama","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.soc.2020.09.004_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/1097-0142(196303)16:3<277::AID-CNCR2820160302>3.0.CO;2-B","article-title":"Hepatic lobectomy for metastatic cancer","volume":"16","author":"Brunschwig","year":"1963","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1997.4727","article-title":"Hepatic resection for metastatic gynecologic carcinomas","volume":"66","author":"Chi","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"26","author":"Winter","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib14","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2003.07.005","article-title":"Resection of recurrent ovarian or fallopian tube carcinoma involving the liver","volume":"91","author":"Yoon","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-8258(03)00004-0","article-title":"Hepatic resection for metachronous metastases from ovarian carcinoma","volume":"89","author":"Merideth","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.soc.2020.09.004_bib17","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.09.004_bib19","article-title":"Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer","author":"Ang","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ygyno.2007.05.032","article-title":"A\u00a0new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model","volume":"107","author":"Aletti","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/gyno.2001.6312","article-title":"What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"28","key":"10.1016\/j.soc.2020.09.004_bib24","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"9990","key":"10.1016\/j.soc.2020.09.004_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2020.09.004_bib26","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): final analysis of peri-operative outcome","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soc.2020.09.004_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejca.2016.05.017","volume":"64","author":"Onda","year":"2016","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.soc.2020.09.004_bib28","article-title":"Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer","volume":"2019","author":"Coleridge","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.soc.2020.09.004_bib29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ijgc-2019-000682","article-title":"TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33\/AGO-OVAR OP7)","volume":"29","author":"Reuss","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.soc.2020.09.004_bib30","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jamaoncol.2018.2761","article-title":"Defining survivorship trajectories across patients with solid tumors: an evidence-based approach","volume":"4","author":"Dood","year":"2018","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.soc.2020.09.004_bib31","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","article-title":"Ovarian cancer, version 1.2016, NCCN Clinical Practice Guidelines in Oncology","volume":"14","author":"Morgan","year":"2016","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib32","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","author":"Al Rawahi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.soc.2020.09.004_bib34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/bjc.2011.328","article-title":"Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort","volume":"105","author":"Zang","year":"2011","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.soc.2020.09.004_bib35","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/IGC.0000000000000026","article-title":"The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer","volume":"24","author":"Kolev","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"20","key":"10.1016\/j.soc.2020.09.004_bib37","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1902626","article-title":"Secondary surgical cytoreduction for recurrent ovarian cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"15_suppl","key":"10.1016\/j.soc.2020.09.004_bib38","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1200\/JCO.2017.35.15_suppl.5501","article-title":"Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III\/ENGOT ov20","volume":"35","author":"Bois","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2020.09.004_bib39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jamcollsurg.2009.01.007","article-title":"The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship","volume":"208","author":"Nathan","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"issue":"12","key":"10.1016\/j.soc.2020.09.004_bib40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/MLR.0b013e3181f37d5f","article-title":"A\u00a0decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement","volume":"48","author":"Learn","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.soc.2020.09.004_bib41","unstructured":"Longoria TC, Bristow RE. Technique of Liver Resection in Cytoreductive Surgery for Advanced Ovarian Cancer. In: Ayhan A, Reed N, Gultekin M, Dursun P. Textbook of Gynaecological Oncology. Vol 1. 3rd ed. Ankara, Turkey: Gunes Publishing; 2016: 801-808."},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib42","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ygyno.2018.09.028","article-title":"Impact of right upper quadrant cytoreductive techniques with extensive liver mobilization on postoperative hepatic function and risk of liver failure in patients with advanced ovarian cancer","volume":"151","author":"Nasser","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2004.12.038","article-title":"Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors","volume":"97","author":"Mateo","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.soc.2020.09.004_bib44","first-page":"2597","article-title":"CT-guided high-dose-rate brachytherapy of metachronous ovarian cancer metastasis to the liver: initial experience","volume":"31","author":"Collettini","year":"2011","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004836-200105000-00002","article-title":"Radiofrequency ablation of liver tumors","volume":"32","author":"Chong","year":"2001","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"4","key":"10.1016\/j.soc.2020.09.004_bib46","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1067\/msy.2002.127545","article-title":"Radiofrequency ablation of liver tumors: influence of technique and tumor size","volume":"132","author":"Kuvshinoff","year":"2002","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1245\/ASO.2003.03.018","article-title":"Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned","volume":"10","author":"Bleicher","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2004.01.041","article-title":"Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review","volume":"93","author":"Bojalian","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.soc.2020.09.004_bib49","first-page":"1008","article-title":"Intralesional injection for hepatic metastasis from cervical carcinoma. A report of two cases","volume":"46","author":"Chao","year":"2001","journal-title":"J\u00a0Reprod Med"},{"issue":"6","key":"10.1016\/j.soc.2020.09.004_bib50","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s10147-014-0665-7","article-title":"Local control and prognostic significance of transarterial treatment for limited recurrence of ovarian cancer as third-line and beyond therapy","volume":"19","author":"Seki","year":"2014","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/annonc\/mdi052","article-title":"Intra-arterial hepatic chemotherapy in heavily pretreated patients with epithelial ovarian cancer","volume":"16","author":"Mambrini","year":"2005","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.soc.2020.09.004_bib52","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.ejso.2019.06.023","article-title":"Prognostic factors value of germline and somatic BRCA in patients undergoing surgery for recurrent ovarian cancer with liver metastases","volume":"45","author":"Gallotta","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"26","key":"10.1016\/j.soc.2020.09.004_bib53","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.soc.2020.09.004_bib54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/bjc.2012.376","article-title":"Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review","volume":"107","author":"Borley","year":"2012","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1006\/gyno.1994.1038","article-title":"Surgical stage IV endometrial carcinoma: a study of 47 cases","volume":"52","author":"Goff","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/gyno.1997.4838","article-title":"The role of surgical cytoreduction in stage IV endometrial carcinoma","volume":"67","author":"Chi","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/gyno.2000.6110","article-title":"The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma","volume":"81","author":"Bristow","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib58","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/ijgc-00009577-200209000-00008","article-title":"FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival","volume":"12","author":"Memarzadeh","year":"2002","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.soc.2020.09.004_bib59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/WHE.09.26","article-title":"Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature","volume":"5","author":"Barlin","year":"2009","journal-title":"Womens Health (Lond)"},{"issue":"6","key":"10.1016\/j.soc.2020.09.004_bib60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1477-2574.2010.00192.x","article-title":"Hepatic resection for metastatic endometrioid carcinoma","volume":"12","author":"Knowles","year":"2010","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.bjc.6605157","article-title":"Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?","volume":"101","author":"Vandenput","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10585-019-10007-0","article-title":"Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes","volume":"37","author":"Gardner","year":"2020","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib63","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/gyno.1998.5037","article-title":"Hepatic metastases from carcinoma of the uterine cervix","volume":"70","author":"Kim","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.soc.2020.09.004_bib64","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.2147\/CMAR.S203037","article-title":"Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer","volume":"11","author":"Yin","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib65","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0090-8258(92)90059-R","article-title":"Hepatic resection for metastatic squamous cell carcinoma from the uterine cervix","volume":"44","author":"Kaseki","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib66","first-page":"1659","article-title":"Upper abdominal resection for isolated metastatic lesions in recurrent cervical cancer","volume":"38","author":"Filipescu","year":"2018","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.soc.2020.09.004_bib67","first-page":"3023","article-title":"Hepatic resection for liver metastases from cervical cancer is safe and may have survival benefit","volume":"36","author":"Bacalbasa","year":"2016","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib68","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/1097-0142(19890301)63:5<935::AID-CNCR2820630525>3.0.CO;2-9","article-title":"Patterns of metastasis in uterine sarcoma. An autopsy study","volume":"63","author":"Rose","year":"1989","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2020.09.004_bib69","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00432-008-0422-2","article-title":"Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007","volume":"134","author":"Park","year":"2008","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib70","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2012.02.014","article-title":"Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis","volume":"125","author":"Leitao","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ygyno.2007.02.031","article-title":"Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma","volume":"106","author":"Giuntoli","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib72","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/gyno.2002.6840","article-title":"Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma","volume":"87","author":"Leitao","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib73","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2005.04.029","article-title":"Embolization for hemorrhage of liver metastases from choriocarcinoma","volume":"98","author":"Lok","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"5\u20136","key":"10.1016\/j.soc.2020.09.004_bib74","first-page":"199","article-title":"Hepatic metastasis in gestational trophoblastic neoplasia: patient characteristics, prognostic factors, and outcomes","volume":"59","author":"Barber","year":"2014","journal-title":"J\u00a0Reprod Med"},{"issue":"8","key":"10.1016\/j.soc.2020.09.004_bib75","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/bjc.2015.97","article-title":"Prognostic value of histological type in stage IV ovarian carcinoma: a retrospective analysis of 223 patients","volume":"112","author":"Mizuno","year":"2015","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib76","first-page":"342","article-title":"Liver resection for metastases arising from recurrent granulosa cell tumour of the ovary--a case series","volume":"31","author":"Madhuri","year":"2010","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib77","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/000313480306900511","article-title":"Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumors","volume":"69","author":"Jacobs","year":"2003","journal-title":"Am Surg"},{"key":"10.1016\/j.soc.2020.09.004_bib78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ags3.12322","article-title":"The history of liver surgery: achievements over the past 50 years","volume":"4","author":"Kokudo","year":"2020","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.soc.2020.09.004_bib79","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.21037\/jgo.2019.08.06","article-title":"Hepatic metastasis from colorectal cancer","volume":"10","author":"Kow","year":"2019","journal-title":"J Gastrointest Oncol"},{"issue":"10","key":"10.1016\/j.soc.2020.09.004_bib80","first-page":"4517","article-title":"Clinical outcome of patients with advanced ovarian cancer after resection of liver metastases","volume":"32","author":"Neumann","year":"2012","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.soc.2020.09.004_bib81","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00268-011-1074-y","article-title":"The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma","volume":"35","author":"Kamel","year":"2011","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","article-title":"The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer","volume":"112","author":"Lim","year":"2009","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib83","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/IGC.0b013e3181a7f71e","article-title":"Management of recurrent endometrioid endometrial carcinoma: an overview","volume":"19","author":"van Wijk","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.soc.2020.09.004_bib84","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/ijgc-00009577-200501000-00005","article-title":"Clinical features of hepatic metastasis in patients with ovarian cancer","volume":"15","author":"Loizzi","year":"2005","journal-title":"International Journal of Gynecological Cancer"},{"issue":"3","key":"10.1016\/j.soc.2020.09.004_bib85","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ygyno.2004.03.015","article-title":"Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival","volume":"93","author":"Lambrou","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.soc.2020.09.004_bib86","first-page":"553","article-title":"Surgical stage III endometrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns","volume":"23","author":"Ayhan","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib87","first-page":"506","article-title":"Characteristics, diagnosis and treatment of hepatic metastasis of pure immature ovarian teratoma","volume":"114","author":"Fan","year":"2001","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib88","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/gyno.2000.5841","article-title":"Optimal cytoreductive surgery is an independent prognostic indicator in stage IV epithelial ovarian cancer with hepatic metastases","volume":"78","author":"Naik","year":"2000","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib89","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1072-7515(98)00225-7","article-title":"Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients","volume":"187","author":"Elias","year":"1998","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.soc.2020.09.004_bib90","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00404-010-1750-4","article-title":"Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver","volume":"284","author":"Roh","year":"2011","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib91","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1015-9584(10)60014-0","article-title":"Surgery for isolated liver metastasis of ovarian cancer","volume":"33","author":"Pekmezci","year":"2010","journal-title":"Asian J Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.09.004_bib92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.sla.0000150244.72285.ad","article-title":"Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma","volume":"241","author":"Weitz","year":"2005","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.09.004_bib93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-8258(03)00004-0","article-title":"Hepatic resection for metachronous metastases from ovarian carcinoma","volume":"89","author":"Merideth","year":"2003","journal-title":"Gynecol Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:04:55Z","timestamp":1760961895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320720300818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1055320720300818"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2020.09.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Management of Gynecologic Cancers","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}